Baldwin D, Rudge S
Ealing Hospital, Middlesex.
Br J Hosp Med. 1993;49(7):497-9.
The search for the ideal antidepressant continues. Moclobemide, the first reversible inhibitor of monoamine oxidase type A to enter widespread clinical use, has a number of advantages over traditional monoamine oxidase inhibitors and represents a valuable addition to the antidepressant armamentarium.
对理想抗抑郁药的探索仍在继续。吗氯贝胺是首个广泛应用于临床的A型单胺氧化酶可逆抑制剂，与传统单胺氧化酶抑制剂相比有诸多优势，是抗抑郁药物中的一项重要补充。
